GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Rangering i aksjer
#3667
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Aksjekurs
$27.17
Markedsverdi
$4.60B
Endring (1 dag)
-1.33%
Endring (1 år)
-13.30%
Land
IN
Handel GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Kategori
Healthcare
Historikk for aksjesplitt for GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Aksjen GlaxoSmithKline Pharmaceuticals Limited (symbol: GLAXO) har gjennomgått totalt 1 aksjesplitt.
Den nyeste splittelsen skjedde Sep 11, 2018.
Én GLAXO-aksje kjøpt før Sep 11, 2018 tilsvarer i dag 2 GLAXO-aksjer.
Den nyeste splittelsen skjedde Sep 11, 2018.
Én GLAXO-aksje kjøpt før Sep 11, 2018 tilsvarer i dag 2 GLAXO-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| 2018-09-11 | 2:1 | x2 | x2 |
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 4 | x15 |
US
|
|
| 7 | x432 |
US
|
|
| 0 | - |
US
|
|
| 7 | x226 |
US
|
|
| 2 | x10000 |
CH
|
